Works matching IS 03125963 AND DT 2025 AND VI 64 AND IP 2
Results: 10
Identifying the Optimal Sampling Strategy for the Bayesian Estimation of Vancomycin AUC<sub>0–24</sub> in Adult Hematologic Cancer Patients: Bayesian Estimation of Vancomycin AUC<sub>0–24</sub> in an Adult Population with Hematologic Cancer: A. Duong et al
- Published in:
- Clinical Pharmacokinetics, 2025, v. 64, n. 2, p. 297, doi. 10.1007/s40262-025-01478-4
- By:
- Publication type:
- Article
Population Pharmacokinetic Modelling of Apixaban in End-Stage Kidney Disease Patients with Atrial Fibrillation Receiving Haemodialysis: Population Pharmacokinetics of Apixaban in Haemodialysis: C. Konecki et al.
- Published in:
- Clinical Pharmacokinetics, 2025, v. 64, n. 2, p. 307, doi. 10.1007/s40262-025-01476-6
- By:
- Publication type:
- Article
Population Pharmacokinetics of Telmisartan in Healthy Subjects and Hypertensive Patients: PopPKs of Telmisartan in Healthy Subjects and Hypertensive Patients: I. H. Jeong et al.
- Published in:
- Clinical Pharmacokinetics, 2025, v. 64, n. 2, p. 285, doi. 10.1007/s40262-024-01471-3
- By:
- Publication type:
- Article
Improving Understanding of Fexofenadine Pharmacokinetics to Assess Pgp Phenotypic Activity in Older Adult Patients Using Population Pharmacokinetic Modeling: Improving Understanding of Fexofenadine Pharmacokinetics: F. Gaspar et al.
- Published in:
- Clinical Pharmacokinetics, 2025, v. 64, n. 2, p. 275, doi. 10.1007/s40262-024-01470-4
- By:
- Publication type:
- Article
Physiologically Based Pharmacokinetic Model of Cefotaxime in Patients with Impaired Renal Function: PBPK Modeling of Cefotaxime in Patients with Kidney Disease: F. Zbib et al.
- Published in:
- Clinical Pharmacokinetics, 2025, v. 64, n. 2, p. 257, doi. 10.1007/s40262-024-01469-x
- By:
- Publication type:
- Article
Population Pharmacokinetics of Meropenem Across the Adult Lifespan: Population Pharmacokinetics of Meropenem: A. E. Boutzoukas et al.
- Published in:
- Clinical Pharmacokinetics, 2025, v. 64, n. 2, p. 229, doi. 10.1007/s40262-024-01465-1
- By:
- Publication type:
- Article
Dose Optimization of Vancomycin in Pediatric Post-Cardiac Surgery Patients: A Population Pharmacokinetic Modeling Study: Dose Optimization of Vancomycin in Pediatric Post-Cardiac Surgery Patients: J. Kamp et al.
- Published in:
- Clinical Pharmacokinetics, 2025, v. 64, n. 2, p. 243, doi. 10.1007/s40262-024-01463-3
- By:
- Publication type:
- Article
Clinical Pharmacokinetics of N,N-Dimethyltryptamine (DMT): A Systematic Review and Post-hoc Analysis: Clinical Pharmacokinetics of N,N-Dimethyltryptamine: K. V. van der Heijden et al.
- Published in:
- Clinical Pharmacokinetics, 2025, v. 64, n. 2, p. 215, doi. 10.1007/s40262-024-01450-8
- By:
- Publication type:
- Article
All You Need to Know About Allometric Scaling: An Integrative Review on the Theoretical Basis, Empirical Evidence, and Application in Human Pharmacology: Theoretical Allometry for Human Pharmacology, a Theoretical and Empirical Overview: D. W. van Valkengoed et al
- Published in:
- Clinical Pharmacokinetics, 2025, v. 64, n. 2, p. 173, doi. 10.1007/s40262-024-01444-6
- By:
- Publication type:
- Article
Clinical Pharmacokinetics of Antitubercular Drugs in the Overweight and Obese Population: Implications for Dosage Adjustments: Pharmacokinetics of Antitubercular Drugs in the Overweight and Obese Population: M. Prager et al.
- Published in:
- Clinical Pharmacokinetics, 2025, v. 64, n. 2, p. 193, doi. 10.1007/s40262-024-01442-8
- By:
- Publication type:
- Article